Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

PSYKIATRISK LÆGEKLINIK HANS MØRCH JENSEN ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.7%   Bankruptcy risk   2.0% 1.5% 1.6% 1.5% 1.7% 1.5% 11.6% 9.2%   Credit score (0-100)   70 77 75 75 73 75 21 27   Credit rating   A A A A A A BB BB   Credit limit (kDKK)   0.1 6.1 6.5 13.3 4.4 19.8 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   489 607 602 533 1,007 744 0.0 0.0   EBITDA   295 543 541 472 946 683 0.0 0.0   EBIT   250 543 541 472 946 683 0.0 0.0   Pre-tax profit (PTP)   219.6 712.0 708.5 823.5 496.1 1,154.0 0.0 0.0   Net earnings   169.2 554.2 551.7 641.9 384.8 892.2 0.0 0.0   Pre-tax profit without non-rec. items   220 712 708 824 496 1,154 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   1,105 1,609 2,111 2,703 3,037 3,880 3,705 3,705   Interest-bearing liabilities   0.0 0.0 0.0 0.0 36.6 63.6 0.0 0.0   Balance sheet total (assets)   1,166 1,751 2,208 2,777 3,168 4,069 3,705 3,705   Net Debt   -1,046 -1,632 -2,114 -2,575 -3,007 -3,869 -3,705 -3,705     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   489 607 602 533 1,007 744 0.0 0.0   Gross profit growth   -10.7% 24.0% -0.7% -11.5% 88.9% -26.1% -100.0% 0.0%   Employees   0 0 0 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,166 1,751 2,208 2,777 3,168 4,069 3,705 3,705   Balance sheet change%   8.1% 50.1% 26.1% 25.8% 14.1% 28.5% -9.0% 0.0%   Added value   295.0 543.3 540.7 471.6 945.7 682.8 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -89 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   51.2% 89.6% 89.7% 88.5% 93.9% 91.7% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   26.6% 44.5% 37.3% 34.2% 37.3% 34.7% 0.0% 0.0%   ROI %   28.4% 47.9% 39.7% 35.4% 38.4% 35.8% 0.0% 0.0%   ROE %   16.2% 40.8% 29.7% 26.7% 13.4% 25.8% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   94.7% 91.9% 95.6% 97.3% 95.9% 95.3% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -354.4% -300.3% -391.0% -545.9% -317.9% -566.6% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 1.2% 1.6% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 3,345.2% 203.2% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   17.9 12.3 22.6 37.2 24.2 21.5 0.0 0.0   Current Ratio   17.9 12.3 22.6 37.2 24.2 21.5 0.0 0.0   Cash and cash equivalent   1,045.6 1,631.8 2,114.0 2,574.7 3,043.3 3,932.7 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   272.8 134.8 85.6 261.1 316.6 119.6 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 472 946 683 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 472 946 683 0 0   EBIT / employee   0 0 0 472 946 683 0 0   Net earnings / employee   0 0 0 642 385 892 0 0